. 2016 Aug 26;24(2):394–397. doi: 10.1093/jamia/ocw127

Table 3.

Changes in the quality of care during progress from Meaningful Use stages 1 to 2

				Physician Delivery of Care, Mean %^a
	Physicians, No.			All Physicians			PCPs			Non-PCPs
Clinical Quality Measure	All	PCPs	Non-PCPs	MU1	MU2	P-value^b	MU1	MU2	P-value^b	MU1	MU2	P-value^b
Clinical Quality Measure	No.			%		P-value^b	%		P-value^b	%		P-value^b
Hypertension: <140/90 mmHg, Age 18–85	667	117	550	35	40	<.01	67	67.5	29	35	<.01
Influenza immunization	89	75	14	63	68	<.01	66	73	<.01	49	44.3
Tobacco use assessment/cessation intervention	637	117	520	86	96	<.01	82	96	<.01	87	95	<.01
Diabetes: HbA1c <9.0%	503	114	389	93	96	<.01	90	95	<.01	95	94.2
Chlamydia screening, age 16–24	604	115	489	10	9	.1	17	13	.2	9	8	.4
Weight screening/follow-up, Age 18–64	672	119	553	32	32	.3	31	31	.3	32	33	.5
Weight screening/follow-up, age ≥ 65	635	117	518	54	49	<.01	54	49	<.01	53	49	.5

^aUnweighted means of individual physician scores.

^bThe frequency with which an eligible physician delivered high-quality care to her/his patients during MU1 was compared to the same physician’s performance during MU2 by paired t-test. HbA1c, hemoglobin A1c; MU, meaningful use; PCPs, primary care physicians.